ICI Survival Gains 'Less Impressive' in Older Lung Cancer Patients

(MedPage Today) -- The introduction of immune checkpoint inhibitors (ICIs) for advanced non-small cell lung cancer (NSCLC) in 2015 has resulted in meaningful survival gains for younger patients, but gains were far more modest among older patients...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news